//
sign in
Post
by @danabra.mov
PostEmbed
by @danabra.mov
Record
by @jimpick.com
Record
by @atsui.org
+ new component
Post
Summarizing the current state of pricing and coverage for GLP1s in the US with @rachelsachs.bsky.social in @nejm.org this week! Read it before things change (again)! www.nejm.org/doi/full/10....
6mo
Insurance Coverage and Pricing of Weight-Loss Drugs in the United States | NEJM
The Trump administration’s agreements regarding glucagon-like peptide 1 receptor agonists could reduce prices and improve access for some patients — and lead to substantial additional spending.
www.nejm.org
Stacie Dusetzina